Featured Research

from universities, journals, and other organizations

Nearly half of U.S. adults with high blood pressure have it under control

Date:
October 22, 2012
Source:
American Heart Association
Summary:
Nearly half of US adults with high blood pressure reported theirs was under control by 2010. The increase in blood pressure control may be due to more use of multiple drug combinations. Older people, blacks and people with diabetes and chronic kidney disease have higher rates of high blood pressure and Mexican-Americans are least likely to take blood pressure medications.

Nearly half of U.S. adults with high blood pressure had their blood pressure under control by the end of 2010 -- a significant increase from the start of the decade, researchers reported in the American Heart Association journal Circulation.

Improvements in blood pressure control were most likely due to wider use of multiple drug combinations , researchers said.

Researchers at the National Center for Health Statistics (NCHS) interviewed 9,320 hypertensive participants in the National Health and Nutrition Examination Survey (NHANES) 2001-10. By the end of 2010, 47 percent had controlled blood pressure -- up from 29 percent 10 years earlier.

The in-person survey is the first to compare blood pressure control rates before and after the Joint National Committee (JNC7) treatment guidelines were published in 2003.

Under JNC7 guidelines, many patients may need combination therapy with two or more drugs to achieve adequate blood pressure control.

In the study, almost two-thirds of those on combination therapy had controlled blood pressure by 2010, and the use of multiple drugs increased from 37 percent in 2001 to 48 percent by 2010.

Compared with using one drug, single and multiple-pill combinations were associated with 55 percent and 26 percent increased likelihood of control, respectively.

"Much progress has been made in blood pressure control over the last 10-year period and the use of multiple drug combinations apparently has had an effect," said Qiuping Gu, M.D., Ph.D., an epidemiologist at the NCHS.

Lower cost of medications and their availability in generic form as well as increased awareness of the risk of uncontrolled high blood pressure has also had a positive effect.

But some issues continue to be problematic, researchers said.

The national hypertension treatment guidelines recommended thiazide diuretics as initial drug therapy for most patients with uncomplicated hypertension, yet their overall use remains comparatively low. In addition, "nearly half of the hypertensive population is not being treated with combination therapy," said Charles F. Dillon, M.D., Ph.D., co-author of the study.

Moreover, rates were lower for older Americans, African-Americans and people with diabetes and chronic kidney disease. Mexican-Americans were least likely to take any kind of blood pressure medication.

"While there are possibly several factors involved, more needs to be learned about why only 34 percent of Mexican-Americans with hypertension have their blood pressure under control," Gu said. Participants were only asked about medications used in the prior month, so those who might have taken medications previously were classified as non-users.

Furthermore, NHANES blood pressure measurements were only collected one time, so some people in the study may have been misclassified.

Other co-authors are: Vicki L. Burt, Sc.M., R.N.; Charles F. Dillon, M.D., Ph.D.; and Sarah Yoon, Ph.D. Author disclosures are on the manuscript.

NCHS is part of the U.S. Centers for Disease Control and Prevention.

For high blood pressure information visit www.heart.org/hbp .


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Journal Reference:

  1. Q. Gu, V. L. Burt, C. F. Dillon, S. Yoon. Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension: The National Health and Nutrition Examination Survey, 2001 to 2010. Circulation, 2012; 126 (17): 2105 DOI: 10.1161/CIRCULATIONAHA.112.096156

Cite This Page:

American Heart Association. "Nearly half of U.S. adults with high blood pressure have it under control." ScienceDaily. ScienceDaily, 22 October 2012. <www.sciencedaily.com/releases/2012/10/121022162541.htm>.
American Heart Association. (2012, October 22). Nearly half of U.S. adults with high blood pressure have it under control. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2012/10/121022162541.htm
American Heart Association. "Nearly half of U.S. adults with high blood pressure have it under control." ScienceDaily. www.sciencedaily.com/releases/2012/10/121022162541.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins